Scott McKeown focuses his practice on post-grant patent counseling and litigation matters at the US Patent and Trademark Office (USPTO) and related appeals to the US Court of Appeals for the Federal Circuit (CAFC). Scott handles all aspects of post-issuance patent proceedings, with a particular focus on administrative trials before the Patent Trial and Appeal Board (PTAB).
View profileBio/pharma patents are rarely targeted in inter partes review (IPR) proceedings because their technical vulnerabilities often relate to written description and/or enablement. IPR, of course, is restri...
On September 21, 2023, the Federal Circuit considered an expectation of success argument in the predictable arts as it related to electro-mechanical assemblies. In Elekta Limited v. Zap Surgical Syste...
An article authored by Scott McKeown titled “New Pair of Federal Circuit Precedents Add Wiggle Room for PTAB Petitioners” was published in IAM. In inter partes review (IPR) proceedings, the scope of a...
An article co-authored by Scott McKeown titled “How Agency Activity is Impacting Patent Litigation This Year” was published in Bloomberg Law. In this article, Scott and his co-authors evaluate federal...
An article co-authored by Scott McKeown titled “A New Era at the PTAB? Director Vidal Issues New Guidance on Discretionary Denials of Institution” was published in Westlaw Today, a Thomson Reuters pub...
An article co-authored by Scott McKeown titled “INSIGHT: Orange, Purple Book Patentees Hone PTAB Survival Skills” was published in Bloomberg Law. In this article, Scott and his co-authors how patent o...